These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21649998)

  • 1. [Selected markers in early prediction of preeclampsia].
    Hasko M; Biringer K; Biskupská BK; Danko J
    Ceska Gynekol; 2011 Apr; 76(2):135-9. PubMed ID: 21649998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging new biomarkers of preeclampsia.
    Polsani S; Phipps E; Jim B
    Adv Chronic Kidney Dis; 2013 May; 20(3):271-9. PubMed ID: 23928393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers for predicting pre-eclampsia.
    Baumann MU; Bersinger NA; Surbek DV
    Mol Aspects Med; 2007 Apr; 28(2):227-44. PubMed ID: 17532461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery Doppler and prediction of preeclampsia.
    Lovgren TR; Dugoff L; Galan HL
    Clin Obstet Gynecol; 2010 Dec; 53(4):888-98. PubMed ID: 21048456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis.
    Allen RE; Rogozinska E; Cleverly K; Aquilina J; Thangaratinam S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():194-201. PubMed ID: 25305662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester serum markers to predict preeclampsia.
    Huppertz B; Kawaguchi R
    Wien Med Wochenschr; 2012 May; 162(9-10):191-5. PubMed ID: 22717872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
    Masoura S; Kalogiannidis IA; Gitas G; Goutsioulis A; Koiou E; Athanasiadis A; Vavatsi N
    J Obstet Gynaecol; 2012 Oct; 32(7):609-16. PubMed ID: 22943702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population.
    Diguisto C; Le Gouge A; Piver E; Giraudeau B; Perrotin F
    Prenat Diagn; 2013 Nov; 33(11):1070-4. PubMed ID: 23847040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation.
    Sekizawa A; Purwosunu Y; Farina A; Shimizu H; Nakamura M; Wibowo N; Rizzo N; Okai T
    BJOG; 2010 Apr; 117(5):557-64. PubMed ID: 20121832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine artery Doppler in first-trimester pregnancy screening.
    Bahado-Singh RO; Jodicke C
    Clin Obstet Gynecol; 2010 Dec; 53(4):879-87. PubMed ID: 21048455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.